Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sohag University
Aromatase inhibitors (AI) therapy is an important treatment for estrogen receptor-positive breast cancer (BC). This work evaluated the eye anterior segment changes in estrogen-dependent BC after hormonal treatment.
This cross-sectional study was conducted on female patients aged ≥18 who received treatment for BC. Patients were evaluated by a number of tests to determine the effects on the cornea and the lacrimal system
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Females diagnosed with breast cancer
You may not be if
uncontrolled diabetes , auto immune diseases
Clareo Health | Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment
